Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Operating Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Operating Expenses for 9 consecutive years, with $24.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 12.44% to $24.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $103.4 million, a 25.2% increase, with the full-year FY2024 number at $88.7 million, up 7.86% from a year prior.
  • Operating Expenses was $24.4 million for Q3 2025 at Neuronetics, down from $25.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $26.8 million in Q1 2025 to a low of $17.0 million in Q1 2021.
  • A 5-year average of $21.3 million and a median of $20.7 million in 2024 define the central range for Operating Expenses.
  • Biggest YoY gain for Operating Expenses was 46.03% in 2021; the steepest drop was 10.8% in 2021.
  • Neuronetics' Operating Expenses stood at $18.4 million in 2021, then grew by 17.08% to $21.5 million in 2022, then decreased by 6.21% to $20.2 million in 2023, then surged by 30.53% to $26.4 million in 2024, then decreased by 7.34% to $24.4 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Operating Expenses are $24.4 million (Q3 2025), $25.8 million (Q2 2025), and $26.8 million (Q1 2025).